CurrentCapital BluecrossPolicy MP 6.015

Airway Clearance Devices

Defines medical necessity and coverage criteria for airway clearance devices (oscillatory PEP devices, high-frequency chest compression systems, mechanical percussors) for outpatient use and who may qualify.

Policy Summary

PayerCapital Bluecross

PolicyAirway Clearance Devices

Policy CodePolicy MP 6.015

Change TypeNo material changes

Effective DateJan 1, 2026

Next Review Date

Key ActionObtain prior authorization with documentation of demonstrated need, failed or intolerant standard chest physical therapy, and compliance during an initial trial.

SourceLink

POLICY UPDATE CHANGES

No material clinical or coverage changes in this revision.

30-dayinitial trial period required

10 monthsmax rental before purchase

CF; Bronchiectasis; NMDprimary diagnoses

FDA 510(k)regulatory consistency

>20references

Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.

Coverage Criteria for Airway Clearance Devices

Mechanical percussors

Considered medically necessary when ALL of the following are met:

Mechanical percussor medical necessity: Mechanical percussors may be considered medically necessary for mobilizing secretions in individuals with chronic obstructive lung disease, chronic bronchitis, or emphysema, when the individual or operator of the powered percussor has received appropriate training by a physician or therapist and no one competent to administer manual therapy is available.

High-frequency chest compression systems / IPV - initial coverage

Considered medically necessary when ALL of the following are met:

Eligible diagnoses: Individual has diagnosis of cystic fibrosis OR chronic diffuse bronchiectasis (defined as daily productive cough for at least six continuous months, or exacerbations >2 times per year requiring antibiotic therapy and confirmed by high-resolution or spiral chest CT) OR neuromuscular disease with associated respiratory weakness.

Demonstrated need and prior therapy: There is demonstrated need for airway clearance; AND standard chest physical therapy is unavailable or not tolerated, with documented clinical evidence of poor or failed outcomes using conventional chest physical therapy (i.e., frequent severe exacerbations with inability to clear mucus despite standard treatment and, if appropriate, use of an oscillatory PEP device).

Trial and compliance: There is individual/family compliance with the device as evidenced by an initial trial period.

Regulatory consistency: Use of the device is consistent with U.S. Food and Drug Administration (FDA) approval.

High-frequency chest compression systems - continuation of coverage

Continued coverage after a 30-day trial is considered medically necessary when BOTH of the following are met:

Usage documentation: Documentation that the device has been used daily or as prescribed.

Clinical response: Documentation of increased expectoration of mucus.

Oscillating PEP devices

Considered medically necessary when ALL of the following are met:

Indication: Individual has hypersecretory lung disease (produces excessive mucus) with difficulty clearing secretions and recurrent disease exacerbations.

Covered Indications (codes listed)

Covered when medically necessary (codes listed)

{\"operator\":\"any\",\"n\":0,\"label\":\"Covered indications\",\"text\":\"Use of listed airway clearance device procedure codes (A7025, A7026, E0480, E0481, E0483, E0484, S8185) is associated with the diagnoses listed (e.g., cystic fibrosis [E84.x], chronic bronchitis/COPD/emphysema [J41.x/J43.x/J44.x], bronchiectasis [J47.x, Q33.4]).\",\"threshold\":\"\",\"note\":\"This section lists codes and associated diagnoses; clinical eligibility follows the medical necessity criteria above.\",\"children\":[]}

This policy applies to outpatient use of airway clearance devices only. Inpatient device use, including use in the immediate postoperative period, is not included within this policy and is excluded from these coverage criteria. Trial selection and device type should reflect outpatient clinical needs and the fact that responses to different devices vary among individuals.

Coverage determinations in this policy are subject to the member's benefit program and eligibility on the date of service. These medical policy statements do not guarantee coverage or payment; final adjudication is based on the member's contract terms, applicable benefit limitations, and any exclusions in the member's plan.

Use of high-frequency chest wall compression systems and intrapulmonary percussive ventilation (IPV) devices for indications other than those specifically described in this policy (and many applications in COPD) is considered investigational due to insufficient evidence of net health benefit. Oscillatory devices may be appropriate as alternatives for individuals who cannot perform manual chest physical therapy, but off-label or broader use beyond the specified diagnoses and criteria is not supported by the evidence summarized in this policy.

This portion of the document does not list an explicit, itemized set of conditions labeled "not medically necessary." Providers should interpret investigational or unsupported uses and exclusions described elsewhere in the policy, and confirm coverage decisions against the member's contract and benefit limits.

Coding and Diagnosis References

FDA product codesmixed

BYI	FDA product code (oscillatory devices)
BYT	FDA product code (oscillatory devices)

Covered when medically necessary (procedure/device codes)HCPCSCovered

A7025	Listed procedure/device code
A7026	Listed procedure/device code
E0480	Listed procedure/device code
E0481	Listed procedure/device code
E0483	Listed procedure/device code
E0484	Listed procedure/device code
S8185	Listed procedure/device code

Referenced diagnosesICD-10

E84.0	Cystic fibrosis with pulmonary manifestations
E84.11	Meconium ileus in cystic fibrosis
E84.19	Cystic fibrosis with other intestinal manifestations
E84.8	Cystic fibrosis with other manifestations
E84.9	Cystic fibrosis, unspecified
J41.0	Simple chronic bronchitis
J41.1	Mucopurulent chronic bronchitis
J41.8	Mixed simple and mucopurulent chronic bronchitis
J43.0	Unilateral pulmonary emphysema [MacLeod's syndrome]
J43.1	Panlobular emphysema

1–10 of 19

1/2

Chronic diffuse bronchiectasis — definition and thresholds

Clinical definitionChronic diffuse bronchiectasis: daily productive cough for at least six continuous months, or >2 exacerbations per year requiring antibiotic therapy, confirmed by high-resolution or spiral chest CT.

Primary associated diagnosesListed as an eligible diagnosis for high-frequency chest compression/IPV alongside cystic fibrosis and neuromuscular disease with respiratory weakness.

Use contextSpecifically referenced as an indication qualifying individuals for airway clearance device coverage when other policy criteria are met.

Prior Authorization, Documentation, and Billing Guidance

Prior Authorization

Prior Authorization / Eligibility Verification Recommended

Prior authorization is recommended. Verify member benefits, eligibility on the date of service, and medical necessity prior to providing airway clearance devices. Contact Capital Blue Cross Provider Services or Member Services for questions about coverage determinations.

Verify member benefits and eligibility prior to service
Confirm medical necessity and appropriate coding before submitting claims

Denial Risk

Device Coverage Contingent on Failure/Intolerance/Unavailability of Standard Chest Physical Therapy

Coverage is contingent on demonstrated need for airway clearance and on failure, intolerance, or unavailability of standard chest physical therapy. The device is medically necessary only when there is documented clinical evidence of poor or failed outcomes using conventional chest physical therapy (e.g., frequent severe exacerbations with inability to clear mucus despite standard therapy) or when standard therapy cannot be tolerated or is unavailable.

Background and Scope

Oscillatory airway clearance devices — including oscillating PEP devices (for example, Flutter and Acapella) and high-frequency chest wall oscillation systems — are alternatives to manual chest percussion and postural drainage to mobilize mucus. Some oscillatory devices require active patient participation, while others (such as passive vest-type systems) provide external chest oscillation. These devices may benefit patients who cannot perform or do not have caregivers to perform manual chest physical therapy, but evidence across indications (cystic fibrosis, bronchiectasis, COPD) is limited and heterogeneous, and additional robust trials are needed to establish net health benefit.

Definitions

Chest physical therapy — definition

DefinitionChest physical therapy refers to manual chest percussion and postural drainage.

Technique componentsManual chest percussion: rhythmic manual tapping to mobilize secretions; postural drainage: positioning to use gravity to assist airway clearance.

Role in policyStandard chest physical therapy is the referenced first-line airway clearance method; device coverage is contingent on unavailability or intolerance of standard therapy per policy requirements.

510(k) — FDA premarket submission

Definition510(k) is a premarketing submission made to the FDA to demonstrate that a device is substantially equivalent to a legally marketed device not subject to PMA.

PurposeTo compare the new device to one or more similar devices currently on the U.S. market and support substantial equivalency claims.

Policy Summary

PayerCapital Bluecross

PolicyAirway Clearance Devices

Policy CodePolicy MP 6.015

Change TypeNo material changes

Effective DateJan 1, 2026

Next Review Date

Key ActionObtain prior authorization with documentation of demonstrated need, failed or intolerant standard chest physical therapy, and compliance during an initial trial.

SourceLink

On This Page

Device coverage requires prior trial and failure/intolerance of standard chest physical therapy or documented unavailability
Oscillatory PEP devices may be considered when standard therapy fails or is not tolerated

Documentation Required

Documentation During 30-Day Trial

Document daily use during the initial trial and clinical response. Documentation must demonstrate the device was used daily or as prescribed and show increased expectoration of mucus. At the end of a 30-day trial, include review of compliance and evidence of stable or improved respiratory status to justify continued rental or purchase.

Record daily prescribed use and adherence during the 30-day trial
Document increased expectoration and clinical improvement or stabilization
If ongoing therapy is medically necessary, rental may continue up to 10 months, after which purchase may be considered

Billing Rule

Claims Coding Recommendations

Claims should include appropriate HCPCS procedure codes and supporting diagnosis codes. Include procedure codes for the device supplied or rented and relevant ICD-10 diagnosis codes that justify medical necessity.

Include HCPCS codes: A7025, A7026, E0480, E0481, E0483, E0484, S8185
Support claims with relevant ICD-10 diagnosis codes (e.g., E84.0–E84.9, J41.*, J43.*, J44.*, J47.*, Q33.4)

Denial Risk

Denial Risk Factors

Lack of demonstrated need, absence of a prior trial of standard chest physical therapy (or missing documentation of intolerance/unavailability), or incomplete trial documentation may result in denial of coverage. Ensure all required documentation and prior authorization steps are completed to reduce denial risk.

Failure to document need for airway clearance can result in noncoverage
Missing evidence of trial, compliance, or clinical response increases denial risk

Note

Coverage/Payment Conditions

This policy and payment are subject to the member's benefit program, eligibility on the date of service, and determination of medical necessity. Treating providers remain responsible for medical advice and treatment decisions.

Coverage/payment subject to member benefit program and eligibility
Medical necessity determination required for payment

Regulatory relevancePolicy requires device use to be consistent with FDA approval; many oscillatory devices cited in the policy have been cleared via the 510(k) process.

Oscillation — definition and device context

Definition in device contextOscillation: a swinging, pendulum-like movement; in airway clearance devices this refers to oscillatory pressure or motion used to loosen mucus and mobilize secretions.

Device examplesApplies to intra- or extra-thoracic oscillatory components such as high-frequency chest compression vests and oscillating PEP handheld devices (e.g., Flutter, Acapella).

MechanismOscillations create pressure and airflow fluctuations that can vibrate airways and loosen mucus when frequency approximates pulmonary system resonance.

CHEST PHYSICAL THERAPY — restated definition

Restated definitionCHEST PHYSICAL THERAPY refers to manual chest percussion and postural drainage.

Policy implicationDesignated as the standard airway clearance therapy; device alternatives are considered when manual therapy is unavailable or not tolerated.

Terminology noteTerm used interchangeably with manual chest percussion and postural drainage in policy definitions.

OSCILLATION — brief definition

Concise definitionOSCILLATION: a swinging, pendulum-like movement applied in airway clearance devices to produce pressure or flow fluctuations that mobilize mucus.

Clinical applicationUsed in both vest-type high-frequency chest compression systems and handheld oscillating PEP devices to enhance expectoration.

CharacteristicMay be intra-thoracic (within airways) or extra-thoracic (external vibration), and may require active patient participation depending on device type.

510(k) — alternate wording

Definition (alternate wording)A 510(k) is a premarketing submission to FDA to demonstrate that the device to be marketed is substantially equivalent to a legally marketed device not subject to premarket approval (PMA).

Comparison requirementApplicants must compare their 510(k) device to one or more similar devices currently on the U.S. market and support their substantial equivalency claims.

Relevance to coveragePolicy notes regulatory consistency with FDA clearance as a criterion for device coverage decisions.